Tahmineh Darvishi has obtained her Diploma in Biology in 2003 from the Goethe University Frankfurt am Main. During her previous work at the Georg-Speyer-Haus as a research technician in the lab of Professor Groner she gathered experience in various molecular and cell-culture techniques. Currently, she is in charge of experimental projects and duties as Laboratoy Manager for the lab of Dr. Farin.
Constantin Menche has studied Molecular Medicine at Goethe University Frankfurt am Main and worked in his master thesis on the plasticity of colonic epithelial stem cells as well as the establishment of efficient gene targeting methods. In 2017 he has started his PhD on the role of stromal Zeb1 during CRC progression, that is part of the DFG research group FOR 2438: Cell Plasticity in Colorectal Carcinogenesis.
Dr. Mohammed Mosa
Dr. Mohammed Mosa obtained his master degree in 2014 from the KU Leuven at the Lab of Massimiliano Mazzone (Belgium). In 2019 he passed his PhD in GSH research group on the topic Role of Wnt Signaling in the Tumor Microenvironment of Colorectal Cancer. Mohammed is employed as a Staff Scientist for the Frankfurt Cancer Institute (FCI) coordinating the development of patient-derived organoid models. He is also associated with the EU-project EUbOPEN for pharmacological testing of colorectal cancer models.
Dr. Benardina Ndreshkjana
Dr. Benardina Ndreshkjana graduated in pharmacy at the University of Milan (Italy) and holds a PhD from University Hospital Erlangen. Headed by Prof. Dr. rer. nat. Regine Schneider-Stock in the Department of Experimental Tumor Pathology, Benardina analyzed mechanisms to overcome chemoresistance. Her research at GSH is funded by the EU-project (IMI2) EUbOPEN and aims to understand drug-resistance mechanisms in patient-derived tumor organoids.
Patricia Schult-Dietrich studied biology at the University in Hamburg, where she also received her diploma on the genetics of sooty moulds. After working four years in geriatric care, she first worked as a technician at the Heinrich Pette Institute - Leibniz Institute for Experimental Virology in Hamburg. Since 2000 she has been working at the GSH as a technician, from 2010 in the group of Dr. Ursula Dietrich and since 2020 she is part of the organoid biobank of the Frankfurt Cancer Institute.
Sara Stier has obtained an education as research technician in Wiesbaden and subsequently studied biology at the Technical University of Darmstadt where she obtained her Bachelor degree. At GSH she has jointed the team to develop drug-screening assays as part of the EU-project EUbOPEN.